A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Public ClinicalTrials.gov record NCT03044249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tolerability, Pharmacokinetics, and Efficacy of MP-101 in the Treatment of Patients With Dementia-Related Psychosis and/or Agitation and Aggression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Study identification
- NCT ID
- NCT03044249
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2017 (Actual)
- Primary completion
- Jan 30, 2020 (Actual)
- Completion
- Jan 30, 2020 (Actual)
- Last update posted
- Apr 1, 2021
2017 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dignity Health (St. Joseph Hospital and Medical Center) | Phoenix | Arizona | 85013 | — |
| Neuro-Therapeutics Inc | Pasadena | California | 91105 | — |
| Associated Neurologists of Southern CT | Fairfield | Connecticut | 06824 | — |
| Marcus Neuroscience Institute | Boca Raton | Florida | 33486 | — |
| Meridien Research | Brooksville | Florida | 34601 | — |
| Galiz Research | Hialeah | Florida | 33016 | — |
| Galiz Research | Miami Springs | Florida | 33166 | — |
| CNS | Orlando | Florida | 32801 | — |
| Parkinson's Disease Treatment Center of SW Florida | Port Charlotte | Florida | 33980 | — |
| Meridien Research Inc | St. Petersburg | Florida | 33709 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| College Park Family Care Neuro | Overland Park | Kansas | 66212 | — |
| J. Gary Booker, MD, Clinical Trials | Shreveport | Louisiana | 71104 | — |
| Alzheimer's Research Corporation | Paterson | New Jersey | 08759 | — |
| Clarity Clinical Research | East Syracuse | New York | 13057 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10312 | — |
| Neurology Diagnostics Inc | Dayton | Ohio | 45459 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03044249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2021 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03044249 live on ClinicalTrials.gov.